SEC 13F Intelligence

Aquilo Capital Management, LLC / KYMR

Aquilo Capital Management, LLC’s Kymera Therapeutics Inc Position

Does Aquilo Capital Management, LLC own Kymera Therapeutics Inc (KYMR)? Not currently — the last reported position was 138.5K shares worth $4M in Q1 2025; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$4M
Q1 2025
Shares
138.5K
% of Portfolio
+6.80%
Quarters Held
11
position exited

Position History KYMR

Reported value by quarter
Q3 ’22: $7MQ3 ’22Q4 ’22: $16MQ1 ’23: $18MQ1 ’23Q2 ’23: $15MQ3 ’23: $11MQ3 ’23Q4 ’23: $22MQ1 ’24: $16MQ1 ’24Q2 ’24: $10MQ3 ’24: $10MQ3 ’24Q4 ’24: $7MQ1 ’25: $4MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2025138.5K$4M+6.80%
Q4 2024183.5K$7M+11.13%
Q3 2024208.7K$10M+7.49%
Q2 2024328.7K$10M+9.46%
Q1 2024388.7K$16M+11.71%
Q4 2023881.3K$22M+13.98%
Q3 2023782.2K$11M+9.85%
Q2 2023651.3K$15M+8.30%
Q1 2023601.3K$18M+7.38%
Q4 2022629.4K$16M+5.90%
Q3 2022330.2K$7M+2.59%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aquilo Capital Management, LLC’s full portfolio or all institutional holders of KYMR.